The National Task force for COVID-19, constituted by Indian Council of Medical Research, recommended the use of hydroxychloroquine as prophylaxis (preventive drug) of SARS-COV-2 infection for high risk population on 23 March.
The following high-risk population can be put under chemoprophylaxis with hydroxychloroquine:
• Asymptomatic Healthcare Workers involved in the care of suspected or confirmed cases of COVID
• Asymptomatic household contacts of laboratory confirmed cases
In the United States, President Donald Trump hailed the drug as something that could counter coronavirus, but health experts have expressed reservations ever since.
In this video, we try to gather the basics of what we know about the drug and its possible use in the future.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.